Merck & Co., Inc. (MRK)
111.11
+1.66
(+1.52%)
USD |
NYSE |
Jan 21, 16:00
111.00
-0.11
(-0.10%)
After-Hours: 20:00
Merck Market Cap: 275.78B for Jan. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 185.02B |
| Gilead Sciences, Inc. | 160.18B |
| Regeneron Pharmaceuticals, Inc. | 78.75B |
| Cidara Therapeutics, Inc. | 6.962B |
| Moderna, Inc. | 19.46B |
Market Cap Related Metrics
| PE Ratio | 14.70 |
| PS Ratio | 4.382 |
| PEG Ratio | 0.252 |
| Price to Book Value | 5.319 |
| Price to Free Cash Flow | 21.46 |
| Price | 111.11 |
| Earnings Yield | 6.80% |
| PEGY Ratio | 0.2398 |
| Operating PE Ratio | 11.01 |
| Normalized PE Ratio | 13.01 |